login
login
Image header Agence Europe
Europe Daily Bulletin No. 12520
Contents Publication in full By article 19 / 36
EU RESPONSE TO COVID-19 / Health

Green light for conditional approval of antiviral drug Remdesivir in EU

03/07/2020 (Agence Europe)The European Commission authorised on Friday 3 July the conditional approval of the antiviral drug Remdesivir (see EUROPE 12519/2). This drug is the first one authorised in the European Union to treat Covid-19. Experts believe it is effective and has few side effects, although further testing during treatments is still needed. Permitted through a fast-track procedure, this conditional authorisation comes only one week after a positive recommendation from the European Medicines Agency (EMA) and after approval by the Member States. “We grant this authorisation less than one month after the application has been filed. This shows the EU's determination to react quickly as soon as treatment becomes available”, said Health Commissioner Stella Kyriakides in a statement. More info at: https://bit.ly/3eYwpSO (MB)

Contents

ECONOMY - FINANCE - BUSINESS
SECTORAL POLICIES
INSTITUTIONAL
EU RESPONSE TO COVID-19
SECURITY - DEFENCE
EXTERNAL ACTION
SOCIAL AFFAIRS
NEWS BRIEFS
CALENDAR
CALENDAR EXTRA